Exclusive

Publication

Byline

Location

US Patent Issued to CROSSJECT on Oct. 27 for "Pharmaceutical hydrocortisone solution for injection device" (French Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,413, issued on Oct. 27, was assigned to CROSSJECT (Dijon, France). "Pharmaceutical hydrocortisone solution for injection device" was invent... Read More


US Patent Issued to National Chung Hsing University on Oct. 27 for "Method for treating cancer using human mitochondrial malic enzyme 2 inhibitor" (Taiwanese Inventor)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,415, issued on Oct. 27, was assigned to National Chung Hsing University (Taichung City, Taiwan). "Method for treating cancer using human mi... Read More


US Patent Issued to Coolhouse Resourcing on Oct. 27 for "Composition, article and method for affecting a mammal" (Colorado, Minnesota Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,416, issued on Oct. 27, was assigned to Coolhouse Resourcing LLC (Minneapolis). "Composition, article and method for affecting a mammal" wa... Read More


US Patent Issued to YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM on Oct. 27 for "Dilutable formulations of cannabinoids and processes for their preparation" (Israeli Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,417, issued on Oct. 27, was assigned to YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (Jerusalem). "Diluta... Read More


US Patent Issued to LUNELLA BIOTECH on Oct. 27 for "Alkyl-TPP compounds for mitochondria targeting and anti-cancer treatments" (Canadian Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,418, issued on Oct. 27, was assigned to LUNELLA BIOTECH INC. (Ontario, Canada). "Alkyl-TPP compounds for mitochondria targeting and anti-ca... Read More


US Patent Issued to PLEX PHARMACEUTICALS on Oct. 27 for "Pharmacological agents for treating conditions of the eye" (California Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,419, issued on Oct. 27, was assigned to PLEX PHARMACEUTICALS INC. (San Diego). "Pharmacological agents for treating conditions of the eye" ... Read More


US Patent Issued to BioMedical Research Group on Oct. 27 for "Cancer chemotherapy supporting agent, food, and drug" (Japanese Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,420, issued on Oct. 27, was assigned to BioMedical Research Group Inc. (Tokyo). "Cancer chemotherapy supporting agent, food, and drug" was ... Read More


US Patent Issued to Societe des Produits Nestle on Oct. 27 for "Compositions and methods using a combination of oleuropein and quercetin for use in cartilage degeneration" (Swiss, French Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,421, issued on Oct. 27, was assigned to Societe des Produits Nestle S.A. (Vevey, Switzerland). "Compositions and methods using a combinatio... Read More


US Patent Issued to Yale University on Oct. 27 for "Blockade of miR4661-3p binding to IL-17A mRNA with site-specific target site blocker prevents neuro-inflammatory-mediated disease" (Connecticut Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,422, issued on Oct. 27, was assigned to Yale University (New Haven, Conn.). "Blockade of miR4661-3p binding to IL-17A mRNA with site-specif... Read More


US Patent Issued to Sony Group on Oct. 27 for "Automated synthesis of polymeric dual drugs" (Washington Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,773,423, issued on Oct. 27, was assigned to Sony Group Corp. (Tokyo). "Automated synthesis of polymeric dual drugs" was invented by Tracy Matra... Read More